| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Etsy (ETSY) | Goldman Sachs | $100.00 | n.a. | |||
| OpGen (OPGN) | Maxim Group | $37.40 | n.a. | |||
| RainDance Technologies (RAIN) | BofA Merrill Lynch/ Cowen/ Evercore ISI | $60.00 | n.a. | |||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Good Technology (GDTC) | J.P. Morgan/ BofA Merrill Lynch/ Barclays | $100.00 | n.a. | |||
| Summit Materials (SUM) | Citigroup/ Goldman Sachs/ BofA Merrill Lynch/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets | 22.22 | $17.00 | $19.00 | $400.00 | 2-Stars |
| Viking Therapeutics (VKTX) | Laidlaw & Company (UK) Ltd. | $57.50 | 1-Star | |||
| Yulong Eco-Materials (YECO) | Axiom Capital Management/ Cuttone/ | 2.50 | $6.25 | $7.25 | $16.88 | N/C |
| N/C = No Call | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 2, 2015 | Manager(s) | Offered | Raised | Price | 3/6/15 | Change |
| Summit Therapeutics plc (SMMT) | JMP Securities/ Oppenheimer & Co. | 3.45 | $34.16 | $9.90 | $10.29 | 3.94% |
| MaxPoint Interactive (MXPT) | Goldman Sachs/ Deutsche Bank Securities/ Pacific Crest Securities | 6.50 | $74.75 | $11.50 | $9.76 | -15.13% |
